COMPLETE PLATFORM – ANSM APPROVAL FOR CLINICAL / COMMERCIAL QC

2 C CARACTERISATION DE LA PLUME GEOMETRY
cpg2

METHOD DEVELOPMENT & VALIDATION

Stability indicating methods, Forced degradation studies – QbD – Extractables and Leachables -Validation – Analytical transfer

Lab

QUALITY CONTROL for clinical / commercial batches

Stability at all conditions : 25°C/60%RH – 30°C/65%RH, 30°C/75%RH, 40°C/75%RH, 30°C/75%RH, 25°C/40%RH, 40°C/NMT 25%RH, cycling conditions, 2-8°C, -20°C
Real time use (in-use)
Chromatography: HPLC, UPLC, UV, Fluorescence, DAD, GC-FID, API, excipient content, degradation product, residual solvents
Water determination: volumetric titration, LOD, TGA
Specific tests for tablets, inhaled products (ex dissolution, NGI, HIAC, Spay Pattern, Plume geometry)

DEVELOPMENT SUPPORT

PHYSICAL PROPERTIES CARACTERISATION :
Compatibility studies, prediction of raw material behaviour (humidity, temperature, solvent)

PHARMACEUTICAL DEVELOPMENT STUDIES
CTD P2 section + respiratory forms

DEVICE DEVELOPMENT
inhalation device, plasters, syringues, physical characterisation

P1080011
labo HPLC1
labo HPLC3
enceintes
enceintes 2
1 B LABORATOIRE Extension Parc HPLC